LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 118 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.60 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 400 | -96.7% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 12,100 | -94.1% | 0.00% | -100.0% |
| Q3 2017 | $947,000 | +535.6% | 206,110 | +126.9% | 0.04% | +620.0% |
| Q2 2017 | $149,000 | +44.7% | 90,838 | -30.1% | 0.01% | +25.0% |
| Q1 2017 | $103,000 | -65.2% | 129,936 | +111.1% | 0.00% | -63.6% |
| Q4 2016 | $296,000 | -58.1% | 61,554 | -16.2% | 0.01% | -65.6% |
| Q3 2016 | $706,000 | +66.9% | 73,437 | +36.4% | 0.03% | +45.5% |
| Q2 2016 | $423,000 | -2.5% | 53,837 | -4.8% | 0.02% | -24.1% |
| Q1 2016 | $434,000 | +70.2% | 56,552 | +27.6% | 0.03% | +107.1% |
| Q4 2015 | $255,000 | – | 44,324 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $78,084,000 | 100.00% |
| Artal Group S.A. | 57,517,977 | $1,039,349,000 | 20.58% |
| NEA Management Company, LLC | 2,382,286 | $43,048,000 | 1.93% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $645,000 | 1.72% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 809,666 | $14,631,000 | 0.67% |
| MOODY ALDRICH PARTNERS LLC | 42,180 | $762,000 | 0.53% |
| Cupps Capital Management, LLC | 62,549 | $1,130,000 | 0.49% |
| BRIDGER MANAGEMENT, LLC | 336,966 | $6,089,000 | 0.41% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 258,353 | $4,668,000 | 0.34% |
| Round Table Services, LLC | 21,611 | $391,000 | 0.23% |